Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Alessio Piraino"'
Autor:
Antonino Di Stefano, Francesca Dossena, Isabella Gnemmi, Silvestro Ennio D’Anna, Paola Brun, Bruno Balbi, Alessio Piraino, Antonio Spanevello, Francesco Nucera, Vitina Carriero, Francesca Bertolini, Mauro Maniscalco, Ian M. Adcock, Gaetano Caramori, Fabio L. M. Ricciardolo
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Identification of COPD patients with a rapid decline in FEV1 is of particular interest for prognostic and therapeutic reasons. Objective To determine the expression of markers of inflammation in COPD patients with rapid functional
Externí odkaz:
https://doaj.org/article/99e754ddc55e464b92dedc9b4ae49c18
Autor:
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri, Nicola Scichilone
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 16 (2022)
Although bronchodilators are the cornerstone in chronic obstructive pulmonary disease (COPD) therapy, the treatment with a single-agent bronchodilator may not provide adequate symptoms control in COPD. The combination of drugs with different mechanis
Externí odkaz:
https://doaj.org/article/288faeea132447c79a7264c4c9d7eca2
Autor:
Antonino Di Stefano, Roberto Frairia, Fabio L. M. Ricciardolo, Isabella Gnemmi, Antonella Marino Gammazza, Alessio Piraino, Francesco Cappello, Bruno Balbi, Maria Graziella Catalano
Publikováno v:
Canadian Respiratory Journal, Vol 2020 (2020)
Chronic obstructive pulmonary disease (COPD) is due to structural changes and narrowing of small airways and parenchymal destruction (loss of the alveolar attachment as a result of pulmonary emphysema), which all lead to airflow limitation. Extracorp
Externí odkaz:
https://doaj.org/article/18b29c4aeec04190a8fe1084c3c89b3b
Autor:
Alfredo Chetta, Nicola Facciolongo, Cosimo Franco, Laura Franzini, Alessio Piraino, Carmelina Rossi
Publikováno v:
Therapeutics and Clinical Risk Management. 18:965-979
In recent years, the perspective of management of respiratory disease has been gradually changing in light of the increasing evidence of small airways as the major site of airflow obstruction contributing to the development of both COPD and asthma al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84a33581777297f2cf1b11c76b06f78
https://doi.org/10.2147/tcrm.s369876
https://doi.org/10.2147/tcrm.s369876
Autor:
Luigi Santoiemma, Eleonora Volpato, Maria Giulia Marini, Gianluca Danesi, Filomena Bugliaro, Salvatore D'Antonio, Luca Cavalieri, Alessio Piraino, Paolo Banfi, Ignazio Grattagliano, Stefano Centanni, Alfio Pennisi, Enrico Peterle
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of COPD, Vol Volume 16, Pp 2181-2201 (2021)
International Journal of COPD, Vol Volume 16, Pp 2181-2201 (2021)
Eleonora Volpato,1â 3 Stefano Centanni,4 Paolo Banfi,3 Salvatore DâAntonio,5 Enrico Peterle,6 Filomena Bugliaro,7 Ignazio Grattagliano,8 Alessio Piraino,9 Luca Cavalieri,9 Alfio Pennisi,10 Gianluca Danesi,11 Luigi Santoiemma,12 Maria Giulia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bffea80873451d62a7109f665da8ae3
http://europepmc.org/articles/PMC8318732
http://europepmc.org/articles/PMC8318732
Autor:
Davide D'Angelo, Veronica Chierici, Eride Quarta, Giada Varacca, Luca Cavalieri, Alessio Piraino, Andrea S. Melani, Fabio Sonvico, Francesca Buttini
Publikováno v:
International journal of pharmaceutics. 631
It has long been accepted that suspension pressurized metered-dose inhalers (pMDIs) must be shaken if a correct dose is to be delivered, if not, it will usually be higher than the label claim. The purpose of this work was to investigate the influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037e40ea54d4f6d65fdb9ef0cdc4a34c
https://pubmed.ncbi.nlm.nih.gov/36535456
https://pubmed.ncbi.nlm.nih.gov/36535456
Autor:
Giada Varacca, Davide D'Angelo, Stefania Glieca, Luca Cavalieri, Alessio Piraino, Eride Quarta, Fabio Sonvico, Francesca Buttini
Publikováno v:
European Journal of Pharmaceutical Sciences. 183:106385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a9d0e76b3564510596e85cc98c99aa8
https://doi.org/10.1016/j.ejps.2023.106385
https://doi.org/10.1016/j.ejps.2023.106385
Publikováno v:
International Journal of COPD, Vol Volume 16, Pp 159-166 (2021)
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease
Luca Richeldi,1 Alessio Piraino,2 Francesco Macagno,1 Gianluigi Micarelli,2 Eleonora Ingrassia2 1Unità Operativa Complessa di Pneumologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico A, Gemelli, Rome; 2Chiesi Italia S.p.a., Parma,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3923cf1ac2017d74d130371891586da3
https://doi.org/10.2147/copd.s286559
https://doi.org/10.2147/copd.s286559
Autor:
Fulvio Braido, Alessio Piraino, Pierachille Santus, Nicola Scichilone, Alberto Braghiroli, Paola Rogliani
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:1269-1285
The topic of 24-hour management of COPD is related to day-to-night symptoms management, specific follow-up and patients' adherence to therapy. COPD symptoms strongly vary during day and night, being worse in the night and early morning. This variabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::438f153b4f511a2f63fd036f2ed3099a
https://doi.org/10.2147/copd.s240033
https://doi.org/10.2147/copd.s240033
Autor:
Davide D'Angelo, Veronica Chierici, Eride Quarta, Giada Varacca, Luca Cavalieri, Alessio Piraino, Andrea S. Melani, Fabio Sonvico, Francesca Buttini
Publikováno v:
International Journal of Pharmaceutics. 633:122640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf58ea889fee4cf5840c20c024d94234
https://doi.org/10.1016/j.ijpharm.2023.122640
https://doi.org/10.1016/j.ijpharm.2023.122640